PMC:7555630 / 18025-18325
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T157 | 74-82 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T158 | 215-223 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T92 | 38-40 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
T93 | 54-60 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T38 | 108-118 | Chemical | denotes | amantadine | http://purl.obolibrary.org/obo/CHEBI_2618 |
T39 | 122-131 | Chemical | denotes | memantine | http://purl.obolibrary.org/obo/CHEBI_64312 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T107 | 0-300 | Sentence | denotes | Rejdak and colleagues then identified 22 patients who tested positive for SARS-CoV-2 and were taking either amantadine or memantine, and reported that none of these patients developed any clinical manifestations of COVID-19, nor did they report any significant change in their neurologic status [24]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32962001-32388458-44896019 | 296-298 | 32388458 | denotes | 24 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
611 | 41-49 | Species | denotes | patients | Tax:9606 |
612 | 74-84 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
613 | 165-173 | Species | denotes | patients | Tax:9606 |
620 | 108-118 | Chemical | denotes | amantadine | MESH:D000547 |
621 | 122-131 | Chemical | denotes | memantine | MESH:D008559 |
627 | 215-223 | Disease | denotes | COVID-19 | MESH:C000657245 |